Inactivation of JNK1 enhances innate IL-10 production and dampens autoimmune inflammation in the brain.
Inactivation of JNK1 enhances innate IL-10 production and dampens autoimmune inflammation in the brain.
复制标题
JNK1 失活可增强先天性 IL-10 的产生并抑制大脑中的自身免疫炎症。
DOI:
10.1073/pnas.0601155103
复制
发表时间:
2006
影响因子:
11.1
通讯作者:
Flavell,RichardA
中科院分区:
文献类型:
--
作者:
Tran,EliseH;Azuma,Yasu-Taka;Chen,Manchuan;Weston,Claire;Davis,RogerJ;Flavell,RichardA
Environmental insults such as microbial pathogens can contribute to the activation of autoreactive T cells, leading to inflammation of target organs and, ultimately, autoimmune disease. Various infections have been linked to multiple sclerosis and its animal counterpart, autoimmune encephalomyelitis. The molecular process by which innate immunity triggers autoreactivity is not currently understood. By using a mouse model of multiple sclerosis, we found that the genetic loss of the MAPK, c-Jun N-terminal kinase 1 (JNK1), enhances IL-10 production, rendering innate myeloid cells unresponsive to certain microbes and less capable of generating IL-17–producing, encephalitogenic T cells. Moreover, JNK1-deficient central nervous system myeloid cells are unable to respond to effector T cell inflammatory cytokines, preventing further progression to neuroinflammation. Thus, we have identified the JNK1 signal transduction pathway in myeloid cells to be a critical component of a regulatory circuit mediating inflammatory responses in autoimmune disease. Our findings provide further insights into the pivotal MAPK-regulated network of innate and adaptive cytokines in the progression to autoimmunity.